Black individuals had a 2-fold risk of cancer death related to prostate, myeloma, and stomach cancers compared with White ...

The FDA has granted orphan drug designation to the oral agent OPN-6602 for the treatment of patients with relapsed or ...

The American Cancer Society (ACS) has released Cancer Statistics for African American and Black People, 2025. According to the report, the cancer mortality rate declined from 1991 to 2022 by 49% and ...

A new report from the American Cancer Society highlights significant racial disparities in cancer death rates, particularly affecting African Americans.

Genetic testing should be used to help doctors spot high-risk cases of myeloma and enable targeted treatments, say ...

Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis and multiple myeloma/bone metastases from solid tumors.

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

The latest to reach the regulatory stage is teclistamab, one of two bispecifics for multiple myeloma in the late ... from the trial reported at the American Society of Haematology (ASH) congress ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The ...

Trish Parker, a renowned Northeast Ohio artist, and two adult sons traveled to Switzerland during Thanksgiving week. They ...

Chimeric antigen receptor T-cell therapy has been really instrumental in how we treat patients with myeloma. It has really changed the face of how we treat this disease, so since 2021, we've had two ...